You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 雲南白藥漲逾6% Q3扣非淨利潤同比上升21.62%
格隆匯 10-29 10:30
格隆匯10月29日丨雲南白藥(000538.SZ)現報85.66元,漲6.04%,暫成交7億元, 最新總市值1094.2億元。雲南白藥昨晚發第三季度業績公告稱,期內實現營收77.49億元,同比增長13.42%;歸屬於上市公司股東的淨利潤12.95億元,同比增長5.55%;歸屬於上市公司股東的扣除非經常性損益的淨利潤12.01億元,同比增長21.62%。此外據悉,上週五(25日),香港生物醫藥企業中國抗體制藥通過港交所聆訊,同日晚間,雲南白藥發公告稱,為提高自身資金利用效率,更好的藉助資本市場優勢推動公司的戰略佈局、促進整體戰略目標的實現,加速國際化進程,計劃斥資5000萬美元(約合3.5億元人民幣)成其基石投資者。東興證券曾發研報指,雲南白藥作為具有百年曆史沉澱的民族品牌,通過成功的跨界發展實現了品牌競爭力的升級,並有望藉助混合所有制改革開啟新一輪增長。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account